time, a threshold level is presented for new bone formation after applying shock waves to intact bone in vivo. The findings of this study are of considerable significance for preventing unwanted side effects in new approaches in the clinical application of shock waves.
Introduction
For almost 15 years, extracorporeal shock wave therapy has been used in treatment for disorders of the musculo-skeletal system. It has been used, with varying success rates, for conditions such as tendinopathies, delayed bone healing, pseudarthrosis and aseptic femoral head necrosis [1] [2] [3] . When shock waves were found to be effective for the treatment of nonunions in 1991 [4] , numerous groups investigated the effects of shock waves in animal models [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and clinical-experimental applications [15] [16] [17] [18] . Unfortunately, the application of extracorporeal shock wave therapy was not very standardized in terms of the strength and number of the impulses used, making comparisons between studies difficult. Today, the best way to characterize shock waves is the use of the energy 45 flux density (EFD; expressed in mJ/mm 2 ), which can be measured with laser hydrophones and accurately quantifies the applied shock wave energy, independent of the shock wave generator type or voltage setting used [19] .
In recent years, the changes in molecular mechanisms induced by shock waves in tendon and bone have been partly investigated using animal and cell-culture models. Shock waves induce increased vascularization at the tendon-bone interface [20] , increased collagen production and collagen cross-linking [21] , and thereby promote healing of tendons. Shock waves also lead to increased biomechanical stability of tendons reattached to bone [22] . At the same time, high-energy shock waves have been shown to cause tendon damage in a dose-dependent manner [23] [24] [25] . In cell-culture experiments, cells were also damaged by high-energy shock waves [26] . At the cellular level in bone tissue, shock waves interact with numerous transmitter systems, leading to new bone formation in physiological as well as acutely fractured and pseudarthrotic bone [9, [27] [28] [29] [30] [31] [32] [33] [34] [35] . Involvement of growth factors like tumor growth factor (TGF-␤ 1), various bone morphogenetic proteins (BMP) and vascular endothelial growth factor (VEGF-a), or secretion of neurotransmitter substance P has been shown. Together, the activation of underlying molecular signal cascades mediated by kinases like extracellular signal-regulated kinase (ERK), the G-protein RAS and p38 kinase have been elucidated [9, [27] [28] [29] [30] [31] [32] [33] [34] [35] .
For the clinical application of shock waves, the mechanisms of action are very important, but the dose of the shock wave energy is also an important factor. It has been speculated by many authors that the effect of shock waves on bone (under physiologic as well as pathologic conditions) is also energy-dose dependent, but this has not been demonstrated yet. Therefore, the aim of this study was to investigate whether a dose-dependent effect of shock wave application on normal bone exists and to characterize the histological features of the newly formed bone. The results may serve as a guideline for further application of shock waves in clinical studies and could help to define a minimal energy dose that still leads to new bone formation in the rabbit model. In recent publications, remote effects of shock wave application on bone have been described. These effects include humeral head osteonecrosis, pulmonary embolism and tendon damage, particularly when high-energy shock waves with EFD over 0.9 mJ/mm 2 were used [11, 23, 36, 37] . Therefore, for the clinical application of shock waves, it is also very important to define a dose-effect relationship, in order to minimize side effects on the musculoskeletal system and improve the efficacy of this technique.
Materials and Methods

Animals
Thirty female Chinchilla bastard rabbits were investigated [exbreeders, 1 year old, body weight (BW) 4,200-4,900 g, closed femoral growth plates]. Animals were purchased from a provider of animal research models (Charles River, Kisslegg, Germany). During the experimental period, animals were maintained on a 12: 12 h light:dark cycle with lights on at 6:00 a.m. and access to standard food pellets and water ad libitum. Animals were randomly assigned to 1 of 5 groups (n = 6 rabbits per group), differing with respect to the EFD of the applied extracorporeal shock waves (0.0, 0.35, 0.5, 0.9 and 1.2 mJ/mm 2 ; table 1 ). For each animal either the left or the right hindlimb was randomly selected for extracorporeal shock wave application, with the other hindlimb serving as control. All research and animal care procedures were approved by the local district government animal utilization study committee.
Anesthesia
Extracorporeal shock wave application was carried out under deep intravenous anesthesia. Anesthesia was initialized by intravenous injection of a combination of xylazine hydrochlorid (1.5 mg/kg BW) and ketamine (6 mg/kg BW) and was maintained by intravenously applying 2.4 mg/kg BW per hour xylazine hydrochlorid and 10 mg/kg BW per hour ketamine by means of a perfusion pump. During anesthesia, animals were supplied with oxygen by an oxygen mask. Administration of intravenous drugs was terminated immediately after shock wave application.
Extracorporeal Shock Wave Application
After shaving both hindlimbs, animals were positioned for extracorporeal shock wave application as previously described in detail [10] . Extracorporeal shock waves were applied to all animals as 1,500 shock wave pulses at 1 Hz frequency during 25 min. Shock waves with EFD of either 0.0 mJ/mm 2 (sham treatment), 0.5 mJ/mm 2 , 0.9 mJ/mm 2 or 1.2 mJ/mm 2 (n = 6 animals per group) were applied to the distal femoral region of the selected hindlimb using an electrohydraulic shock wave source (XL1; Dornier MedTech, Wessling, Germany). The shock wave device was coupled to the selected distal femoral region by means of a water bath. Two laser pointers adjusted in 2 planes controlled focusing of the shock waves to the distal femur, the waves were directed from the 2 could not be generated with the electrohydraulic device, shock wave application at this EFD (n = 6 animals) was carried out with an electromagnetic shock-wave source (EPOS Ultra; Dornier MedTech, Germany). The shock wave source was coupled to the distal femoral region at the same region as with the XL-1 device ( fig. 1 a) by means of clinically used ultrasound jelly between application device (cylinder) and skin. Shock wave focusing to the distal femur was controlled by an outline ultrasound-system (7.5 MHz linear scan) integrated into the shock wave device.
Prior to each shock wave application, the EFD of the focus zone was measured with a laser hydrophone (Imotec, Mühlanger, Germany) [11, 38, 39] . By this approach, it is possible to compare the effects of different shock wave generators (electromagnetic or electrohydraulic). The measured size of the -6 dB focus zone was 5 mm ( fig. 1 a) . This focus zone includes all parts of the shock wave field, where the positive pressure is 1 50% of the peak positive pressure.
In vivo Bone Labeling
All animals received subcutaneous injections of 25 mg/kg BW oxytetracycline (5%; Atarost, Twistringen, Germany) at varying sites of the back at each of days 5-9 after extracorporeal shock wave application, modified from the protocol established by Delius et al. [5] .
Analysis of Bones
Animals were sacrificed by a pentobarbital overdose 10 days after extracorporeal shock wave application. Both femurs were exarticulated in the hip and knee joint, fixed in methanol (100%) for 14 days, dehydrated and block-embedded in methylmethacrylate. Since total femur length varied only between 9.9 cm and 10.2 cm, for the further analysis each specimen was shortened to 5 cm (with a diamond band saw; Exakt, Norderstedt, Germany) for investigation of the focus zone and then cut to 100 m-thick sagittal sections from anterior to posterior using a saw microtome (Leica SP 1600; Leitz, Wetzlar, Germany). Intervals between sections were 800 m, and 5-7 sections were obtained from each femur. Bones were evaluated by means of broad-band epifluorescent illumination, contact microradiography and histological examination using Giemsa-Eosin staining.
Epifluorescent illumination was carried out with a microscope (Axiophot; Zeiss, Göttingen, Germany) using a fluorescent filter system (filter no. 25; Zeiss, Germany), fluorescent light source (HBO-100, Zeiss) and video camera (MC 3255P, Sony, Japan). Quantitative analysis was performed online using an image analysis system (Kontron KS 400; Zeiss). For all femurs, the following parameters were investigated at both the periosteal ventral and dorsal sites as well as at the endosteal ventral and dorsal sites: (1) maximum thickness of new bone formation measured perpendicular from the bone surface and (2) percentage of bone length showing new bone, classified into class 1 (0-33%), class 2 (34-66%) and class 3 (67-100%) ( fig. 1 ). At the beginning of each investigation, the image analysis system was adjusted with a calibrated scale (Zeiss). The precision of the measurements was 8 10 m.
Contact microradiography was performed on high-resolution photo plates (IMTEC, Sunnyvale, Calif., USA) using a Faxitron Microfocus System (Hewlett-Packard; Palo Alto, Calif., USA) with a period of exposure of 60 min at 17 kV and 2 mA. Furthermore, sections were independently and blindly evaluated by 2 pathologists experienced with the musculoskeletal system using a Leitz Dialux 20 EB light microscope (Leitz). For all femora, the following parameters were investigated at the periosteal ventral site and the trabecular bone of the metaphysis and diaphysis: presence of periosteal new bone apposition, periosteal detachment, cortical fractures, and trabecular bone with callus. The data were scored into 3 classes. Class 1 (no sign of the investigated variables, score 1), class 2 (moderate signs of the investigated variables, score 2) and class 3 (distinct signs of the investi- gated variables, score 3). All histomorphometric gradings were assessed independently by 2 pathologists. Any differences between the classification of the 2 pathologists were resolved in conference.
After grinding and polishing (Schleifsystem 400 CS, Exakt), selected specimens were stained using Giemsa-Eosin and evaluated for signs of newly formed bone and callus formation.
Statistical Analysis
For each group of animals, the mean and standard error of the mean (SEM) were calculated for all investigated variables. Comparisons between groups (i.e., between different EFDs) were performed using nonparametric Spearman's rank correlation, separately for the treated and the untreated femora. For the investigation of the maximum thickness of new bone formation, the Wilcoxon matched pairs test was applied for comparisons within groups. In cases of extension of new bone formation, comparisons within groups (i.e., between treated and untreated femora of the same animals) were performed using 2 or Fisher's test, respectively. The latter test was used if one class (i.e., 1, 2 or 3) was not recorded for both the treated and the untreated femora. Differences were considered as statistically significant at p ! 0.05. All calculations were carried out using GraphPad Prism version 4.00 for Macintosh (GraphPad Software; San Diego, Calif., USA). 
Results
Extracorporeal shock-wave application to the distal femoral region of the rabbit resulted in macroscopically detectable hematomas in the focus zone of every animal in the group treated with EFD 1.2 mJ/mm 2 and slight hematomas were detected in the animals treated with 0.9 mJ/mm 2 . No hematomas were found in any other animal. Microscopically, clearly detectable, dose dependent signs of new bone formation, mostly on the periosteal-ventral side were found ( fig. 1 ).
With respect to the investigations with epifluorescent illumination, the most distinct effects of shock wave application were found at the periosteal-ventral site of the treated femur. These effects comprised statistically significant positive correlations between the applied EFD, the maximum thickness of new bone formation and the percentage of bone length showing new bone ( fig. 2 and  3 ) . Furthermore, there were statistically significant differences between the treated and the untreated femurs of the same animals at the periosteal-ventral sites for the maximum thickness of new bone formation at EFDs of Moderate effects of shock wave application were found at the periosteal dorsal site of the treated femur. However, statistical significance was only obtained for differences between the treated and the untreated femur of the same animals at EFD of 1.2 mJ/mm 2 for the maximum thickness of new bone formation periosteal-dorsal (p = 0.031) and the percentage of bone length showing new bone periosteal-dorsal (p = 0.013). At the endosteal sites of the femur, no statistically significant effects of the applied shock waves were found. All data of the investigations with epifluorescent illumination are displayed in figures 2 and 3 .
The investigations with contact microradiography revealed statistically significant positive correlations in the treated femura between the applied energy flux density and periosteal new bone apposition [Spearman r (r) = 1.000, p = 0.017], periosteal detachment (r = 0.975, p = 0.017), and cortical fractures (r = 1.000, p = 0.017) at the periosteal ventral site and the trabecular bone of the me- Histologically, these results were confirmed. The newly formed bone was easily discerned by its cell-rich, eosinophilic matrix which showed the typical characteristics of woven bone ( fig. 1 e) . In this area, signs of appositional bone formation were detectable with an increase in resorption lacunes with osteoclasts and a prominent layer of osteoblasts. Cortical fractures were filled with fibrous tissue ( fig. 1 d) and trabecular fractures showed chondrogenic and osteogenic callus tissue ( fig. 1 i) . In contrast, the untreated femur showed no new bone formation ( fig. 1 n) .
Discussion
The investigations were performed on an established animal model of extracorporeal shock wave application to the musculoskeletal system [5, 10] . In line with previous reports of extracorporeal shock wave therapy in animal models [5, 11, 13, 14, 40] , the present study shows shock wave mediated new bone formation. In recent publications a dose-dependent effect has been assumed; however, this was based on only 1 low-dose group receiving 2,000 shock wave impulses with EFD 0.18 mJ/mm 2 and 1 highdose group receiving 4,000 shock wave impulses with EFD of 0.47 mJ/mm 2 in a fracture model [33] . Here, a threshold value for new bone formation is presented, assessing 5 different EFD levels. Extracorporeal shock wave application resulted in a dose-dependent increase of periosteal new bone formation, requiring a minimum dose of 0.5 mJ/mm 2 to create any effect at all in this animal model. The amount of new bone formation then increased with increasing EFD (0.9 and 1.2 mJ/mm 2 , p ! 0.05). When using a high EFD of 1.2 mJ/mm 2 new bone formation was also seen on the dorsal periosteal side of the femur. A remote action of shock waves on new bone formation has already been shown for the ventral cortical bone, but not for the dorsal cortical bone [11] . Trabecular fracturing in the femur condyle also occurred, even with lower EFD. This should be considered by the clinician when calculating possible side effects, especially when using shock waves with a relatively high EFD ( 6 1.2 mJ/ mm 2 ) [7] . Other serious complications, like pulmonary embolism, have been described in the same animal model also using an EFD of 1.2 mJ/mm 2 [36] . Recently, after high-energy shock wave therapy (EFD 0.78 mJ/mm 2 ; 3,000 impulses) for rotator cuff tendinopathy in humans, humeral head osteonecrosis was reported. There was no hint of any etiology other than the shock waves [37] . These unwanted side effects could possibly be minimized when using shock waves with an EFD just high enough to induce new bone formation (in cases of bone stimulation during fracture repair or treatment of pseudarthroses) but not so high as to induce major side effects. Furthermore, when treating soft tissue disorders like tendinopathies with shock waves, new bone formation has to be strictly avoided in order to prevent nerve entrapment syndromes, such as at the elbow or impingement syndromes at the shoulder.
Earlier explanations for shock wave-induced bone formation were based on the concept of mechanically induced microfractures and periosteal detachment [4, 5, 7] . We can here confirm that shock waves lead to cortical fractures, periosteal detachment, trabecular fractures and callus formation. According to Ikeda et al. [7] , microfractures are necessary for the generation of new bone. In our study, we observed periosteal bone apposition with only minimal production of microfractures (EFD 0.5 mJ/ mm 2 ), indicating that this might not be the prevalent mechanism for new bone formation. Similar concerns were previously raised by our group [40] . Furthermore, the release of growth factors (TGF-␤ 1, VEGF-a and BMP) and other mediators (substance P) that affect bone formation has been shown recently in the rabbit and rat models [9, 10, 31, 35] , which suggests other molecular mechanisms may have a role in the induction of new bone formation.
Despite the relatively widespread clinical use of EFD, the physical parameters for its clinical application (the dose and number of shock wave impulses), for the treatment of individual diseases still have to be standardized.
Since now a dose-dependent relationship between shock waves and biological action has been clearly proven, more clinical studies defining suitable EFD and number of shock wave impulses for single diseases have to be performed, especially since this information cannot be directly transferred to the pathological situation of fractured bone or nonunion in human bones. For example, in the treatment of tibial nonunion, Schaden et al. [17] used shock waves with an EFD of 0.4 mJ/mm 2 and 12,000 impulses and achieved union in 26 out of 34 patients. Wang et al. [18] used similar physical parameters, but with EFD a little higher and fewer impulses (EFD 0.62 mJ/mm 2 ; 6,000 impulses). Clinical results were similar. Finally, Rompe et al. [16] achieved healing rates of about 70% of tibial nonunions when using shock waves with EFD 0.6 mJ/mm 2 and 3,000 impulses. Other groups using different physical parameters were not as successful [15] , highlighting the importance of a clearly defined energy dose for shock wave applications.
We conclude that the results presented here have significant impact on further clinical application of shock waves on bone tissue. In the present study, it is clearly demonstrated that the amount of new bone formation is directly dependent on the applied EFD. If the applied EFD is too low, no significant new bone formation will occur. If it is too high, unwanted side effects, like the formation of bone spurs in the shoulder or nerve entrapment syndromes in the elbow or feet by bony overgrowth, may result when treating tendionopathies.
